Joint Scientific Consultation: the balancing act of preparation across regulatory and market access.

In this engaging and insight-packed webcast, our experts discuss when a joint scientific consultation should be considered - from a regulatory and market access perspective and what it takes to prepare and when to consider alternatives.

The webinar covers:
• General requirements and eligibility for Joint Scientific Consultation.
• The topics that are covered - from a regulatory and market access perspective.
• How to prepare from an operational (such as briefing book) and strategic (commercial and strategic implications) perspective.
About the speakers:

Susanne Michel - Vice President of Market Access Europe, Clinigen) has experience from the Department of Health in Berlin and the Department of Health in England.

Graeme Deuchar is a biomedical research professional, has over 10 years’ experience in regulatory affairs consultancy. He has significant experience in leading teams across a range of regulatory applications supporting the development of medicinal products for major global markets. His expertise also involves contributing to the regulatory strategy for product development in multiple therapeutic areas and he regularly engages with Regulatory Agencies.